Showing results (11-20 of 316) with videos related to
Sort By:
Pageof 32
Circulation|May 29, 2008
Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular riskJacoba P Greving, Erik Buskens, Hendrik Koffijberg, et al.Stroke|May 9, 2009
Blood volume measurement to guide fluid therapy after aneurysmal subarachnoid hemorrhage: a prospective controlled studyReinier Hoff, Gabriel Rinkel, Bon Verweij, et al.Stroke|August 9, 2012
Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis updateMervyn D I Vergouwen, Ale Algra, Gabriel J E RinkelThe Lancet. Neurology|June 7, 2011
Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysisMonique Hm Vlak, Ale Algra, Raya Brandenburg, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 17, 2012
Additional risk of hypertension and smoking for aneurysms in people with a family history of subarachnoid haemorrhageIngeborg Rasing, Dennis J Nieuwkamp, Ale Algra, et al.Stroke|February 14, 2004
Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhageWalter M van den Bergh, Ale Algra, Gabriël J E RinkelJournal of Rehabilitation Medicine|September 27, 2007
Effects of Bobath-based therapy on depression, shoulder pain and health-related quality of life in patients after strokeThóra B Hafsteinsdóttir, Jaap Kappelle, Maria H F Grypdonck, et al.Journal of Neurology|January 27, 2009
Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. Comparison of effects after endovascular and neurosurgical aneurysm occlusionWalter M van den Bergh, Ale Algra, Gabriel J E Rinkel, et al.European Stroke Journal|June 15, 2018
Prediction models for clinical outcome after a carotid revascularisation procedure: A systematic reviewEline J Volkers, Ale Algra, L Jaap Kappelle, et al.Stroke|December 13, 2005
Potential consequences for recruitment, power, and external validity of requirements for additional risk factors for eligibility in randomized controlled trials in secondary prevention of strokeSally C Howard, Ale Algra, Charles P Warlow, et al.Pageof 32